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Two bullous pemphigoid antigens (BP As) have been 
identified: a 230-kD intracellular hemidesmosonte-
associated molecule and a 1S0-kD transmembrane 
hentidesmosome-associated molecule. Although pa-
tients with bullous pemphigoid (BP) have been shown 
to have circulating antibodies directed against one or 
both BP As, the antigenic specificity of tissue-bound 
BP autoantibodies has not been studied. Because 
these skin-bound antibodies may play an important 
role in disease initiation, we sought to determine 
their antigenic specificity. III sitll- bound BP anti-
bodies were eluted with glycine from salt-split peri-
lesional skin biopsy specimens and subjected to 
intmunoprecipitation. Ten of 13 patients had gly-
cine-eluted antibodies that recognized the 230-kD 
BPA, whereas four of 13 patients had glycine-eluted 
antibodies ' that recognized the 1S0-kD BPA. When 
B ullou s pemphigoid (BP) is an autoimmune subepider-mal bliste ring skin disease characterized by autoanti-bodies directed aga in st molecules of the e pidermal basement membran e zone. These autoantibod ies bind to antigens in the basement membrane zon e of le-
siona l skin, are found circulatin g in the se ra of these patients, and 
are thought to play an important ro le in the etiopathogenesis of 
bliste r formation [1-4]. C irculating BP antibod ies bind to the 
epidermal hemidesmosome , the organell e that is found at the basal 
pole of basa l keratinocytes and is thought to playa ro le in the 
adhesion of epidermis to the dermis IS- S]. 
Conside rable efForts ha ve been devoted to the immunochemical 
charac te rization of bullo us pemphigoid antigens (BPAs) . These 
studies have identifi ed two distinct hemidesmosomal molec ules: a 
230-kD BPA and a IS0-kD BPA L9,10]. Previous studies had 
suggested that BP autoa n tibod ies recognize epitopes that are both 
intra cellul ar and extracellul ar. These findings can be understood in 
light of recent c loning studies of both 230-kD and 1S0-kO BPA , 
which reveal that the 230-kD EPA is an intracellul ar mol ecu le and 
the 1S0-kO EPA is a transmembrane molecul e LI1-14]. In mct, 
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these glycine-eluted BP skin specimens were sequen-
tially eluted with urea, we found either antibodies of 
the same specificity or loss of reactivity to one of the 
BPAs, but no reactivity to any BPAs previously un-
detected with glycine elution. Sequential elution 
with sodium dodecylsulfate revealed no detectable 
BP antibodies. The heavy- and light-chain isotypes of 
the circulating, tissue-bound, and eluted BP antibod-
ies were very similar, suggesting that we are not 
eluting certain subsets of BP antibodies. Sera from 
these patients contained circulating antibodies that 
recognized either one or both BPAs. Our observa-
tions demonstrate that if! sitl/-bound antibodies 
eluted from the skin of patients with BP are prefer-
entially directed against the 230-kD BPA. Key 1V0rds: 
b 1/ 1I0l/s diseases /lremidesmosomel aI/to; """ 1/ II ity Ibasemellt lIIelll-
bmlle. ] I,,,,est Dem,a.to/ 105:824-830, 1995 
immunoelectron microscopi c studies have clearly demonstrated 
that human autoantibodies directed against the 230-kD EPA bind 
on ly to th e in trace llul ar domain of the hemidesmosome, whe reas 
human autoantibodies directed against the 1S0-kO EPA bind to 
both intra- and extracellul ar portions of the ep idermal hemidesmo-
some [15]. The cDNAs for these two BPAs hybridize with distinct 
tran scrip ts without any cross-hybridization , and molecular genctic 
stud ies have revealed distinct chromosoma l loca lization for these 
two EPAs [16-1S]. 
Although patients w ith BP ha ve both c irculating and ti ssue-
bound antibodies directed aga in st BPAs, almost all effo r ts aimed at 
understanding the etiopathogenesis of bliste r formation in B1' ha ve 
been directed toward characteriz ing the circulating EP antibodies. 
These studies revea led that almost all BP sera bind to the 230-kD 
EPA by both immunoblotting and immunoprccipitation and that 
about SO'y., ofEP sera also bind to the 1S0-kO EPA [9,19,20]. Th is 
l S0-kO BPA is the maj o r <lutoantigen in herpes gestationis, an 
autoiml11une blistering discase of pregnan cy that is closely re lated to 
BP [21]. Because the 230-kD BPA is an intracellular molecule and 
the 1S0-kD BPA is a transmembrane mol ecule, it has bee n sug-
gested that antibodies directed against the 180-kO BPA sho uld 
represent the pathogenic antibodi es as a result of their access ibili ty 
for autoantibody induction, whereas antibodies directed against the 
230-kD EPA ma y represent an epiphenomenon . In fact, recent 
studies have demonstrated that rabbit polyclonal antibodies di-
rected against a EP 1S0 fusion protein, w hich represents the mouse 
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hon'lologue of an extrace llula r e pitope of the human 180-kD BPA 
knovvn to b e important in both BP and h e rpe s ges tationis , can 
reproduce the clinical, histolog ic, and immunopathologic features 
of BP when inj ected into n eon atal mice [21,22] . 
'We reasone d tha t it would b e very important to d e termine th e 
antige nic sp ecifi c ity of the ill sifll skin-bound antibodies in patients 
with BP b ecause these ill lIillo- bound antibodies could play an 
i=portant ro le in the initiation of disease, We studied 13 patie nts 
with BP and found that 10 of 13 patients had elutable skin-bound 
a ntibodies directed aga inst the 230-kD BPA, whereas only four of 
13 patie nts h ad e lutabl e skin-bound antibodies directed against the 
180- kD BPA, demonstrating that BP 230 antibo dies are preferen-
tially e luted from the skin of patie nts with BP. 
MATERJA LS AND METH ODS 
Patients We studied 13 patients diagnosed with BP based upon the 
prese n ce of typical clinical, histologic, and immunopathologic fea tures 
(Table I). Skin biopsy and blood specimens were obtained from patients on 
the same day. Sera from hea lthy vo lunteers were used as normal contro ls. 
All sera were sto red at - SO°C. 
Antibody Elution Spec imens of perilesional hip skin measuring 1 X 1.5 
inches were obtaincd fro m 13 patients with BP. These specimens wcre 
incubated in 1.0 M NaC I con tain ing 2 mM phenylmcthylsul fonyl flu o ride 
for 3 d, with daily changes to induce dermal-epidermal separation [23). 
Before antibody clu tion studies, direct immunofluorescence was performed 
o n a small portion of this salt-split skin . III silll epidermal-bound antibodies 
were e lu ted from the cpidermis by two 3-min washes with 50 mM glycine, 
pH 2.3 at 4°C . T he co llected antibodies were neutralized with four parts 
el u ate to one part 2 M Tris-HC I, pH 7.4, to prevent degradation of 
potentially important antigenic binding sitcs , dialyzed against Tns-buffe red 
saline , and concentrated to 50 f-LI using microconcentrators (Amicon, 
Beverly, MA) . These eluted epidermal antibodies were studied by indirect 
irnrnunofluorescence microscopy for their ability to bind to control nonpa-
ti e nt sa lt-split skin and by immunoprecipitation to dete rmine their antigenic 
specificity. A small portion of the acid-glycine- elu ted epidermis was studied 
by direc t immunofluorcscence to ascertai n how efficientl y acid glycinc 
r e tnovcd bound BP ~ntibod i es . for SOllle of th e spccinlcns, 'we pe rfornlc d 
further sequenti al elution studies with S M urea/ l.0 M NaC I and 1.0'Y., 
sodium dodecylsul f.,te (SDS) to ascertain the antigenic specificity of the ill 
si tll- bound antibodies not eluted by the acid glycine procedure. In these 
exp e rimcnts. the acid-glycine-eluted ep idermis was incubated with S M 
urea/1 M NaCI for 3 min; the collected antibodies were d ialyzed against 
Tris-bu ffe red saline, microconcentrated , and studied by both indirect im-
m un o flu o rescence 111 icroscopy and inllTIUn Opreci pita tion. The urea- eluted 
epide rmis was finally incubated with 1 % SDS for 3 min and processed as 
above . Controls included hip skin obtained at autopsy within 12 h of death 
o r normal breast skin fro m reduction mammoplasties obta ined within 3 h of 
surger y, which was salt split and eluted as described above. 
InllTl unoBuorescence Peril esiona l skin biopsy specimens from patients 
with B P were studied by direct immunofluorescence methods both befo re 
and a fte r antibody e lu tion with acid glycine, urea, and SDS, accordi.ng to 
stand ard te chniques , u sing alblilnin-coated slides . Contro l 110 1"111:11 hUll1 an 
skin obtained fro m reduction mammoplasty was sa lt spli t according to the 
m eth od of Gammon el 01 [23). T he level of the spli t was confirmed by an 
indirect inl1l11lllo Au orcsccnt an tigen-I11apping study, \vhich revealed type 
VlI collagen antibodies binding to the dermal side of the sp lit and BP 
al1tibodies binding to the epidermal side of the spli t skin . We studied the 
ab ili ty of antibodies eluted I]-om the skin of BP patients with acid glycine, 
urea, o r SDS and se ra 6:0111 BP patients to bind to th is control nonpatient 
salt-spli t epidermis. Six-micrometer froze n sections of salt-split skin were 
moun ted on albumin-coated slides and reacted for 1 h at room temperature 
with various dilutions of BP patients' sera or 1:10 dilutions of e lu ted BP 
anti bodies. Afte r washing in phosphate-bull:ered saline , the sections were 
incubated for 1 h at room temperature with fluoresce in-conjuga ted anti-
h un1.an IgG (Tago Inc .. Burlingame, CA) . T he scctions were washed with 
phosp hatc-b u flc rcd sa line and v iewed w ith a Ze iss inllnul1o fiu o rcsccncc 
m icroscope equipped with a camera (Carl Zeiss, German y) . A ll samples 
were tested in dup licate and evaluated inde pe nde ntl y as unknowns by two 
different indi viduals. We. also assayed the heavy- and light-chain isotypcs of 
tbe c irculating, tissue-bo und , and eluted antibodies. Peril esional skin biopsy 
specinlcns frOln pntic n ts w ith BP we re studied by direct il11nluno flu o res-
ce n ce methods before antibody elution, using commercially ava ilable 
poly clonal sheep anti-human 19G t . - 2, -3, and - 4 anribodies as well as sheep 
anti-human kappa and lambda light chains at 1 :200 dilutions, fo llowed by a 
fluoresce in-conjugated donkey anti-sheep IgG antibody at 1 :50 dilution 
IN SITU BO UND ANTIBOD IES IN BP 825 
(The Binding Site , San Diego, CA). To determine tl,e heavy- and light-
chain isotypes of the circulating and the elu ted skin-bound antibodies , we 
used a three-step indirect immunoflu orescence assay with sodium-chlo ride-
split hunlan skin as the substrate. T he skin sec ti ons \vcre incuba ted \v ith 
either BP serum diluted 1:20 or e luted BP antibodies di lu ted 1:10 as the 
primary antibody. then with the polyclonal sheep anti-human antibodies as 
secondary antibodies, and finally with the flu orescein-conjugated donkey 
an ti-sheep IgG antibody. Controls included human tonsil of known kappa 
and lambda light chains and human m yeloma prote ins of known heavy- and 
light-chain isotypes. T he cross-reactivity of each heavy-chain subclass 
antibody with the other heavy-chain subclass antibodies and of the lighr-
chain an t ibod ies \vith each oth er was less than 1 'XI. 
Immunoprecipitatioll ImI11unoprecipitation studies were performed 
using a modification of previously described methods that allowed us to 
identify bo th the 230- and the l S0-kO BPAs [9,24]. Keratinocyte extracts 
were obtained by pulsing SO')!o confluent cul tures of human breast kerati-
nocytes (Cloneti cs , San Diego, CA) with carbon 14 (Amersham, Arlington 
He.ights, IL) fo r 24 h and then extracting with 0.5% Nonidet P-40 along 
witll 2 mM phenylmeth ylsul fony l fluoride , 2 mM ethylenediaminetetraace-
ti c acid , and a cocktail of protease inhibitors including 5 mg/ I each of 
leupeptin , antipain, chymoscatin, and pepsta tin A (Sigma C hemical Co. , St. 
Louis, MO). Cell ex tracts were preabsorbed with normal human serum , 
applied twice to 2 ml of fres hly washed aliquots of staphylococcal protein A 
10% suspension (Pansorbin ; Calbiochem Co. , La J o ll a. CA), and then 
incubated overnight at 4°C with either 15 f-LI ofBP sera or 50 f-LI of eluted 
antibodies. After adding fres hly washed aliquo ts of 150 f-LI protein A 10')!. 
su spensio n to each sanlpie and incubating fo r 1 h 0 11 ice , 'we processed the 
samples as described [9) and analyzed them by SDS-po lyacrylamide gel 
electrophoresis and flu orography . 
RESULTS 
Acid-Glycine Elution of Perilesional BP Skin Removes 
Epidermal-Bound IgG Antibodies ; BP Antibodies Eluted 
With Either Glycine or Urea Bind to the Epidermal Side of 
Salt-Split Skin A ll 13 perilesional BP skin biopsy specim e n s 
displayed Lin ear deposits of IgG aJ1d C3 , w hich b o und to the 
e pidermal side of salt- spli t skin (Fig 1A). Whe n these sp ecim ens 
were e lu ted with acid g lycine, w e w e re able to remove ill silll-
b o und BP antibo dies as evide n ced b y a d ecrease in the inten sity of 
binding to the epiderm al side of the sa lt-split skin (Fig 1B). T h ese 
epidermal glycine- e luted antibodies b o und b ack to the e pidermal 
side of control nonpatie nt sa lt- split skin b y indirect immun oflu o-
rescen ce (Fig 2A). As a control , w e separately e lu ted B P d e rmis 
with acid g lycin e and found that thi s e luate did n o t bind to e ithe r 
side of control nonpatient salt-split skin. B ecau se ac id g lycine did 
not e lute a ll of t he ill sill/-bo und epide rmal antibo dies, we treated 
the acid-g lycine- eluted epide m1is w ith harsh e r extra c tio n con d i-
tions of 8 M ureall M N aCI and fin a lly 1 % 5DS . Ure a-e lu ted BP 
epidermis displayed a furth e r d ecrease in the amo unt of bindin g to 
the e pide rmal side of sa lt-split skin (not sh own), and th ese e pide r-
m al ure a- e lu ted antibodies bound in the indirect immuno flu ores-
cen ce assay, although to a lesser ex tent than th e g lycin e- e lute d 
antibodies , to the e pide rmal side of contro l nonpatie nt salt-spli t skin 
(Fig 2B) . SDS-e lu ted BP epide rmis displayed n o binding to th e 
epidermal side of sa lt-spLit skin , and the e pid erma l SDS-e lute d 
antibo dies did n ot bind a t all to the roof of control n o npatient 
salt-split skin (not sh own). Elutio n ofBP d ermis w i th urea and th e n 
w ith SDS yielded matel'ia l that d id n ot bind to e ithe r side of control 
nonpatient sa lt-split skin. A utopsy hip skin and re duc tion m ammo-
plasty surgical skin w ere sa lt sp lit, and both the e pidermis and 
dermis were e lute d sequ entia lly with g lycine , urea, and SDS as 
d escribed above. All of these contro l-e lu ted materials were tes te d 
b y indirec t immuno flu orescen ce and fa il ed to bind to e ithe r side of 
control nonpatient sa lt-sp li t skin . 
The Most Common Subclass of Antibody Found in the 
Serum, Bound in the Skin, and Eluted From the Skin Is 
IgG4 To d e te rmine w h eth e r acid g lycin e e lu t io n mig ht b e e lu t in g 
a subse t of antibodies, we assayed th e h eavy- and light-c h ain 
isotyp es of the e lute d antibodies and compared the m with th e 
heavy- and ligh t-chain isotypes of the c irc ulating antibodies and 
with the isotyp e of skin-bound antibodie s be fore e lu t io n. T h e m ost 
Table I. Clinical, Histologic, Immunopathologic, and Immunochemical Findings of BP Patients 
Antigenic Specificity o f BP 
Autoantibodies" 
Percent Circulating Eluted 
Patient Body Time From Previous T ypes of 
Number Age/ Sex Histology" DIFb lIF' Invo}venlcnt Disease Onset Treatment Lesions" 180-kD 230-kD 180-kD 230-kD 
78 / M Subepidennal blister IgG 3+ SSS roof 50% 2 weeks None Blisters and mt plaques Wk + ++ + 
w/ L,E, & N C33 + Titer = 2560 
2 80/ F Subepidennal blister IgG 3+ SSS roof 15% 3 years; new None Blisters Wk+ 
w/ L,E, & N C33 + T iter = 320 flare of disease 
3 73 / M Subepidermal blis- IgG 1+ SSS roof 70% 4 years; nc\v None Blisters and mt plaques Wk+ + + 
ters wl E C33 + Titer = 25 60 flare of disease 
4 63 / F Subepidermal blister IgG 2+ SSS roof 50% 1 year; new flare Imuran 50 mg qd for Blisters and mt plaques Wk+ 
w l E C33 + Titer = 640 of disease 1 week 
5 74 / F Subepidermal blister IgG 3 + SSS roof 15% 1 year; new flare None Blisters and urt plaques ++ + 
w/ L,E, & N C33 + Titer = 1280 of disease 
6 78 / M Subepidermal blister IgG 3+ SSS roof 35% 2 months Prednisone 60 mg qd Blisters and urr plaques ++ 
w l E C33+ Titer = 640 X 2 weeks 
7 80/ F Subepidermal blister IgG 3+ SSS roof 15% 1 year; new fl are None Blisters Wk + + Wk+ 
w l E C33 + Titer = 2560 of disease 
8 80/F Subepidermal blister IgG 3+ SSS roof 10% 3 months None Blisters and mt plaques ++ +++ 
w/ L,E, & N C33 + Titer = 80 
9 78 / M Subepidermal blister IgG 3+ SSS roof 20% 1 week None Blisters and urr plaques + ++ 
w l E C33 + Titer = 1280 
10 67/ F Subepidermal blister IgG 3+ SSS roof 40% 1 week None Blisters and urt plaques + + Wk + 
w l E C33 + Titer = 640 
11 84/F Subepidennal blister IgG 1+ SSS roof 25% 6 months; new None Blisters and mt plaques + ++ 
w l E C33+ Titer = 2560 fl are of disease 
12 74/F Subepidermal blister IgG 3+ SSS roof 30% 3 weeks None Blisters Wk + ++ Wk + 
w / L,E, & N C33 + Titer = 320 
13 78/F Subepidermal blister IgG 1+ SSS roof 65% 1 week None Blisters and urr plaques + + ++ 
w/ L,E, & N C33 + Titer = 2560 
" L,E, & N, lymphocytes, eosinophils, and neutrophils. 
b DIF, direct immunofluorescence. All specimens revealed linear deposirs at the epidermal basement membrane zone of the listed irnmunoreactant. 1 + . Positive staining; 2+. bright staining; 3+. very bright staining. 
( lIF, indirect inlmullo fluorescence performed using 1.0 M NaCI split skin as a substrate. SSS , salt-split skin. 
J un. urticarial. 
' Assayed by the imlllunoprecipitation teclmique, described in Materials alld Methods. -, no binding. Wk+ , barely detectable; + , binding; ++, stronger binding; +++ , strongest binding. 
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Figure 1. Acid-glycine elution of perilesional BP skin removes 
epidermal-bound IgG antibodies. A, direct immunofluorescence stud-
ies reveal IgG deposits on the epidermal side of sa lt-spli t hip skin from a Bl' 
patient befo re an tibody e lu tio n. B, direc t immuno flu o rescence studies 
revea l that after glycine elution of the epidermal side of perilcsional skin 
frOln the BP patient in Fig lA, there is a decrease in the amount of 
epid e rnla l-bo und IgG antibodies. Top, stratum corne um; b()(/()(II , epidermal 
baSeD'lent membrane; e, epidermis. Bar, 20 IJ.m . 
comO-Ion subclass of antibody, IgG4, was found circulating in the 
serum, bound in the skin, and eluted fr0111 the skin . Most of the 
oth e r heavy- and lig ht-chain subclass antibodies were also present, 
and no sign ifi ca nt differences w ere observed between the heavy-
and lig ht- chain isotypes of the circulating, tissue-bound, and elu ted 
BP a n tibodies (Table II). 
BP Antibodies Eluted With Glycine Preferentially Recog-
nize the 230-kD BPA; BP Antibodies Eluted With Urea Are 
Either of the Same Immunochemical Specificity as BP 
Antibodies Eluted With Glycine or Display Loss of Reac-
tivity to BPAs Immunoprecipitation studies revealed that 10 of 
13 patients had glycine-eluted antibodies that recognized the 
230-kD BPA, wh ereas four of 13 patients studied had glycine-
, elute d epidermal antibodies that recognized the 'ISO-kD BPA (Fig 
3A,B; Table I). Two patient~ fai led to reveal glycine-elutable 
epidermal antibodies specific for either BPA , whi le one patient had 
circulating antibodies directed against the lSO-kD BPA and e luted 
epidermal antibodies directed aga in st the 230-kD BPA. Glycine 
elution of control autopsy hip skin and normal surgical breast skin 
failed to reveal any antibodies specifi c for either BPA (Fig 3A, la/f/! 
7; Fig 3B, lalfe 6). Urea elutio n of epidermis previously eluted with 
j glycine revealed that two oHive patients had antibodies of the same 
specificity as the glycine-eluted antibodies but of decreased inten-
sity, and three of five patients had loss of reactivity of one of the 
I ,...., SITU 13 0 UND ANT1I30D IES IN Ill' 827 
Figure 2. BP antibodies eluted with either glycine or urea bind to 
the epidermal side of salt-split skin. A , ind irect immunofluorescence 
studies perfo rmed using Ilonpatien t sal t-split skill as a substrate reveal that 
g lycine- eluted fiI' antibodies rem oved frOI11 the epidermal side of I'e ri-
les io nal skin from a BI' patient bind back to the epidermal side of sa lt-sp li t 
ski n . B. indirect inl 111uno Au o rcsccncc studies pcrfo rnl cd u sing Il o npaticnt 
salt-spl it skin as " substrate reveal that urea- eluted fil' antibodies sequen-
tially rem oved fro l11 th e ep idennal side of perilesiona l skin from a B l' patient 
bind th e ep iderma l side of sa lt-sp lit skin, but to a lesser extent th an do 
g lycine- e lu ted antibodies (compare w ith Fig 2A) . Tv!" st[atwn corn e um ; 
"" (('>III , epidermal basem ent m embrane; e, epidermis. Bnr, 20 1J.111. 
BPAs when compared with the glyc in e elu tion (Fig 4; Table III). 
Non e of the urea elu ates revealed the presence of BP 230 or 180 
antibodies that were absent with glycine elution . SDS eluti on of 
ski n previously treated with g lyc in e and urea failed to revea l any 
antibodies specifi c for either BPA b y immuno precipitation in the six 
patients studied (not shown). Beca use it is possible that the process 
of salt splitting the perilesionai skin specimens may cause release of 
BP antigens, we saved this sa lt-splitting bufFe r, microconcentrated 
it, and assayed it by immunoprecipitation. O ne of five patients had 
antibodies directed against the 180-kD BPA, and three of five 
patients h"d antibodies directed against the 230-kD BPA (not 
shown). T he sera obtained at the sam e time as the periJesional skin 
specim ens all contained circul ating antibodies that recogni zed o ne 
o r both BPAs . Eleven of 13 patients had circulating antibodies 
specifi c for the 230-kD BPA. 12 of 1'3 patients had circul ating 
antibo dies specific for the 1S0-kD BPA, and 10 of 13 patients had 
circulating BP antibodies specifi c for both BPAs (Fig 3A,B). 
Contro l human serum obtained from no rmal volunteers failed to 
disp lay circulating antibodies specific fo r eith er BPA . No obvious 
correlation was observed between the antigenic specificity of the in 
lIillo skin-bound BP an tibodies and the circulating BP antibodies. 
Eva lu ation of several clinica l, histologic, and immunopatho logic 
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Table II. The IgG Heavy- and Light-Chain Subclass Specificities o f Circulating, Tissue-Bound, and Eluted BP 
Antibodies Are Very Sitnilar With a Predominance of IgG4" 
Serum Antibody" T issue-Bound Antibody' Elutcd Antibody" 
Patient 
Number Gl G2 G3 G4. /( A G1 G2 G3 G4 /( A G"l G2 G3 G4 K A 
4 + ++ + + + + +++ + + + ++ + 
S :t + + +++ + + :t + + +++ + + :t + + ++ + + 
7 + + +++ + + + + :t ++ + + + + :t ++ + + 
12 + :t + ++ + + :t + ++ + + + ++ +++ + :t 
13 + + + +++ + + + + +++ + :t + + +++ + :t 
" - . Background; +. positiv e linear staining of roar; + + I bright linear sraining of roof: + + +. very hri ght lillen r stain_iug of roof. 
II Assayed by indirect imm un oflu orescence lIsing sa lt-sp li t sk ill and the three-step pro toco l described ill /\II(/I('r;"ls llI~d /V/ctlwds. 
r Assayed by direct irnmunofluorcsccnce and the tWO-step pro tocol d escribed in l\11{J/C''; (//s (/m/ 'l1rllwr!s. 
features of these patients (Table I) did not revea l any correlation 
w ith the antigenic specifi city of the ti ssue-bo und antibod ies. 
DISCUSSION 
We h ave evalu ated the antigenic specificity of e lu ted skin-bound 
autoantibodies in patients with BP and have demonstrated a 
predo minance o f 230-kD BPA-specific antibodies, raising the pos-
sibili ty th at these antibodies could play an initi atin g role in the 
pathogen esis of BP. Because the l S0- kD BPA is a transmembrane 
m o lecule and the 230- kD BPA is an in tracellular molecule, it has 
been presumed that the ciJ'culatin g antibod ies directed aga inst the 
230-kD BPA fou nd in patients with BP represent an epiphenome-
non, w hereas the circulating antibodies directed aga inst the l S0-kD 
BPA are the pathogenic antibod ies. It has been sugges ted that 
patients first develop au toantibodies directed aga inst the lSO-kD 
BPA and that .afte r these antibodies bind and damage the epidermal 
ce ll s, th e 230-kD BPA is m ade accessible, and then antibodies 
direc ted aga inst it are form ed . However, th e resu lts o f the present 
study question th is assumpti on and highli ght the need to understand 
how patients develop tissue-bound antibodies directed against the 
intracellul ar 230-k D BPA. 
It is poss ible that tissue-bo und BP 23 0 antibodies occur as a resul t 
of mino r damage to normal-appearing peril esio nal skin , all owing 
the in tracellular 230- kD BPA to be accessible fo r autoantibody 
in duction . H owever, if this were true we wou ld expect chan ges in 
the perilesional skin , in cl uding e ryth ema , ea rl y bli ste r fo rmation, or 
even decreased time necessary to induce dermal-epidermal separa-
tion by the salt-sp li tti ng techni que. In fact, the perilesional BP skin 
used in these studies appeared compl ete ly norm al and required the 
sa me 3-d period to salt split as did human skin fro m volunteers 
w itho ut HP . T hese observations suggest th at if therc is any damage 
to peril es io nal BP skin , it is min or and undetectab le using the above 
described c rite ria. 
It is also possible that the in tracellul ar 230-kD BPA moves to the 
cell m embran e and is then recognizable to the extracellular milieu 
to indu ce autoa ntibody production . T here is e vidence from the 
epithelia l rat bladder cell Ene S04G, w hich readily fo rms hem ides-
ITI OS0I11 eS ill II ifro, th at unde r certa in conditio n s h CI111dcs I11 0S0111Ul 
compo nents may be mobile within the cell [25] . Furthcr indirect 
support fo r thi s concept is derived fi'om the fi nding th at the 
in trace llul ar R o and La antigens, thought to play an important rol e 
in lupus erythematosus, can be induced by ultrav io le t light to be 
accessible o n the ce ll surface [26,271- A recen t report dem o nstrated 
that trea tment of o rgan-cultured human skin with ultravio le t B 
irrad iation leads to a decrease in the express ion of BPA [2S]. T his 
observatio n raises the possibility that ul travio let irradiation could 
ca use extracellul ar presentation of BPAs, which might then lead to 
their eventu al destruction . T his observation is supported by the 
finding that ul trav io let irradiation of rabbits possess ing hi gh tite rs of 
antibod ies directed against the 230-kD BPA ca uses immunoreactant 
deposition at the epidermal basement membran e [29] . Fin ally, it is 
also conceivabl e that autoantibodies may, under certain circum-
sta nces, penetrate in to the intracellul ar milieu of li ving epithe li al 
cells [30]. 
It would be very important to dete rmine the ultrastructural 
locali zatio n of the binding site o f these ill 5illl- bound skin antibod-
ies to asce rtain whether the 230- kD-specific e luted BP antibodies 
are binding to sites that are at the cell m embran e o r are extracel-
lular. lmmunoelectron microscopic studi es have dem onstrated that 
circul ati ng autoa ntibodies directed aga in st the 230-kD BPA bind 
on ly to the in trace llular do m ain of the hemidesm osome, w hereas 
c ircul ating autoantibodies direc ted against the l S0- kD BPA bind to 
both intra- and extracellular po rtions of the hemidesmosome [1 5] . 
T hese types of studi es perfo rmed on th e eluted BP antibodies 
would g ive va luabl e information regarding the p ossible migration 
of the hemidesmosomal 230-kD BPA w ithin the cell. 
When we performed immunoprecipi tatio n studies to assay the 
sa lt-sp Li tting bufFer used to separa te the epidermis fro m the dermis, 
w e fou nd that only on e of fiv e patients had recoverable BP 1S0 
antibodies and three of five patients had recoverable BP 230 
antibodies. T hese resu lts aid in e limin ating BP l S0 antibody loss 
during sa lt splitting as a m echanism to expl ain our finding that BP 
230 an tibodies are preferentially elu ted fi'o m the skin ofBP patients. 
We have shown th at ill Ili llo- bo und BP antibodies can be elu ted 
£i'om a patient's skin using acid g lycin e and that afterward, th ere are 
decreased bu t still detectabl e IgG antibodies bound to the patient's 
skin . T he acid-glycine- elu ted BP antibodies w ere able to bind back 
to the epidermal side o f non pati en t sa lt- sp li t epide rmis. When 
acid-glycine- treated skin was e lu ted w ith urea, we w ere ab le to 
rcm ove more ill Il illo- bound antibod ies . T he urea-eluted BP anti-
bodies were also ab le to bind back to the epidermal side of 
nonpatient sa lt-split ep idermis , albeit to a lesser extent. Acid-
glycine-elu tcd epidermis yie lded BP antibo dies w ith a predom i-
nance ofBP 230 specifi city. Urea e lu tion of skin, which is a harsher 
method of remov in g antibod ies, yic lded either BP antibodies of the 
sam e specificity as the g lycin e- eluted antibo dies, but of slightly 
diminished in tensity (two of five patients), o r loss of reactivity to 
one o f the BPAs w hen compared with the g lycin e e lu tion (three of 
fiv e patients) . It is importan t that none of the fi ve urea e luates 
revea led DP antibodies tha t were absent with g lyc ine e lution . T hese 
findin gs . along with the observation that SDS elu tion , the harshes t 
m cthod for e luting antibodi es, f.'l il ed to yie ld any detectable DP 
an tibodies by e ither immun ofluorescence o r i111munoprecipitation , 
dem onstra te that the m ethodology used fo r an tibody elu tion suc-
cessfully rem oved ill Il illo-bo und BP antibodies. Furth er support for 
this com es £i'om the hea vy- and light- chain subclass antibody 
studi es, demonstrating very similar heavy- and light- chain profil es 
of the circulating, tissue-bo und , and e lu ted BP antibodies. T hese 
observations dimini sh the likelihood that o ur e lutio n of ill Il;IIo-
bound HP antibodies is removin g a certa in subset of antibodies. 
H o wever , the possibili ty rem ains that antibodies directed aga inst 
BP l S0 m ay be very tightly bo und to the skin and cannot be e luted 
w ith the conditio ns we have used. 
T herc is one report eva luating skin-bound antibo dies obta ined at 
autopsy fi-om a sin gle patient that fo und that the skin-bound 
antibo dy was similar to th e c ircula tin g BP antibody in terms of its 
19G subclass and immunofl uorescence pattern [31] and that the 
e luted skin DP antibody bound to the basement membran e zone of 
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Figure 3. BP antibodies eluted with glycine preferentially recog-
nize the 230-kD BPA. A, resu lts ofillll11unoprecipitation studies ofthrcc 
patients with controls. 13, results of illllllunoprecipi tation studies of five 
different patients with controls. Lanes that show a positive band for either 
the 180- or 230-kD BPA arc marked (dinrIllJ/ld) d ire~tl )' to the left of the 
appropriate band. Five of eight patients had tissue-bound antibodies di-
rected against the 230-kD EPA (A, !tllle I ; 13, Inlles I, 3, 4, 5), whereas two 
of eight patients had tiss ue-bound antibodies directed against the 1 BO-kD 
BPA (A , l illie 5; 13, In lie 4). Six of eight patients had circulating antibodies 
specific for the 230-kD HPA (A, lalles 2, 6; 13, Inll es 8, 9, 10, 11). seven of 
eight patients had circulating antibodies specific fo r the ISO-kD BPA (A, 
lalles 2, 4, 6; 13, Inlles 7, 8, 10, 11). and five of eight patients had circulating 
BP antibodies specific for both EPA s (A , Inll es 2, 6; 13, Inlles 8, '10, / 1). E, 
epide rmal ; S, semlll . 
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Figure 4. BP antibodies eluted with urea are either of the same 
immunochemical specificity as BP antibodies eluted with glycine 
or display loss of reactivity to BPAs. T lus figure shows the resu lts of an 
immunoprecip itation stud)' comparing the antigenic specificities of gl),cine-
and urea-eduted antibod ies. Lnrll' 1. urea-eluted antibodies fi'ol11 patient 10: 
In lie 2, gl),cine-e1uted antibodies from patient 10: Inlle J, urc,,-eluted 
an tibodies from p"tient 12; In lie -I, gl),cinc-elmed antibodies fro l11 patient 12: 
Inllr 5, urea e lution of control Ilo rnlal surgica l sk in. Lanes that sho\:v a 
positive b"nd for either the 230- o r 180-kD EPA arc marked (dinrllolld 01' 
Iriallg l c, respec tivel)') directl ), to the left of the approp ,;nte band . 
normal skin by indirec t immunoAuorescence. Blocking studies 
were u sed to dete rmine that th e lin ear b asem e nt m embrane zon e 
binding of BP sera to normal skin sections was not blocked if skin 
section s were pretreate d w ith e lu ted BP antibo dies , su ggesting that 
serum and skin antibodies may h ave difFerent antigenic specificities 
[31] . Unfortunately, th ese studies w e re performed using autopsy 
skin along with patie nt serum obtained 4 months before death. 
During this 4-mo nth interva l, the patient had a Aare of his BI> 
requiring prednisone t reatment, complicating inte rpretation of 
these already limited blocking studies in a single pati ent. O ur 
immunoprecipitation results , u sing e luted skin antibodies and se-
Table III. Urea-Eluted BP Antibodies Either Have the 
Same Antigenic Specificity as Glycine-Eluted Antibodies 
or Lose Reactivity to BPAs" 
Antigellic Specific it), of Eluted Antibodies" 
GI),cine-Eluted 
Antibodies Urea-Eluted Antibodies 
Patient 
NUlllber ISO-kD 230-kD l SO-kD 230-kD 
+ ++ ++ 
6 ++ + 
10 Wk + ++ ++ 
11 ++ 
12 Wk + ++ Wk + 
No bin ding: Wk +. barely detec tahle; +. hill dinA": + +. stro n ger bi n din g:; 
+ + +. !' trongcsl binding. 
/' Antigenic specifi city or glycinc- .. \ltd urca-eluted :lnrihoclics was ,lss:lycd by the 
iltl ll1l1ll oprccipitatioll technique descrihed ill Mnl!Tinis 1/1/1/ IV/t'llwris. 
830 KOI~AN 
ru m antibodies obta in ed at th e same time from a cohort of patients, 
demonstrate in a direct fa shion that the antigen ic specificities o f 
c ircula ting and skin-bound BP antibodies d ifFer. 
To determine whether ou r findings corre lated w ith any features 
of the patient' s skin disease, we .retrospectively e valu ated the 
clini cal , histologic, and immunopatho logic features of our patients. 
All cases sho wed typ ical findings ofDP. and there was no demon-
strable corre lation between the antigenic specifi city of the e lu ted 
BP antibodies and any clinjca l or laboratory features , in cl udin g 
types of les ions, amo unt of disease, time Ii-om disease onset, 
treatment, histologic features , di rect immuno Auorescence findings, 
indirect immunoAuorescen ce sta ining pattern, or antibody titer. 
All patients displayed circul ating antibodies that bo und sole ly to 
the epidermal side of salt-split human epidermis. Ten of 13 patients 
had circulatin g antibodies directed against both BPAs. T hese 
find in gs arc consonant w ith those of Onodera cl al [32], who 
recentl y demonstrated that all autoantibodies direc ted against the 
230-kD BPA and most autoantibodies directed aga inst the 180-kD 
BPA bind to the epidermal side of sa lt-split ski n . Our findings 
showing a d iffe ren ce between th e antigenic specifi cities of the 
circulating and e lu ted skin-bound BP antibodies are intriguin g and 
demonstrate that antibodies d irected agai nst the 230-kD BPA arc 
prefe rentially e lu ted £i'o m BP patient skin . T he reasons fo r this 
d ifference between the antigen ic specific ities a re not entire ly clear. 
O ur res ults sugges t tha t antibod ies direc ted aga in st the 230-kD 
BPA co uld represent more than an epip henomen on and support the 
co ncept th at an tibod ies directed aga inst the intra cellul ar 230-kD 
HPA may p laya ro le in the initia tio n of skin disease in HP. Further 
studies are necessary to address thi s questio n more directly and to 
ascertain potential mechanisms . 
T";, " '" rk lI ' as SflPIJI,rl('d I,), N al;,,,,a l III .< I;II/I('s of /-lenll" G rnills R55 AR4 1008 
alld R29 A R41008. 
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